The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity

Molecules. 2022 Feb 15;27(4):1293. doi: 10.3390/molecules27041293.

Abstract

A wide variety of oligomeric structures are formed during the aggregation of proteins associated with neurodegenerative diseases. Such soluble oligomers are believed to be key toxic species in the related disorders; therefore, identification of the structural determinants of toxicity is of upmost importance. Here, we analysed toxic oligomers of α-synuclein and its pathological variants in order to identify structural features that could be related to toxicity and found a novel structural polymorphism within G51D oligomers. These G51D oligomers can adopt a variety of β-sheet-rich structures with differing degrees of α-helical content, and the helical structural content of these oligomers correlates with the level of induced cellular dysfunction in SH-SY5Y cells. This structure-function relationship observed in α-synuclein oligomers thus presents the α-helical structure as another potential structural determinant that may be linked with cellular toxicity in amyloid-related proteins.

Keywords: Parkinson’s disease; familial mutations; toxic oligomers; α-helical structure; α-synuclein.

MeSH terms

  • Humans
  • Mutation*
  • Neurodegenerative Diseases
  • Protein Aggregates
  • Protein Aggregation, Pathological / genetics*
  • Protein Aggregation, Pathological / metabolism*
  • Protein Binding
  • Protein Multimerization* / genetics
  • Spectrum Analysis
  • alpha-Synuclein / chemistry*
  • alpha-Synuclein / genetics*
  • alpha-Synuclein / metabolism

Substances

  • Protein Aggregates
  • SNCA protein, human
  • alpha-Synuclein